Screening for monoclonal gammopathy of undetermined significance: A population-based randomized clinical trial. First results from the Iceland screens, treats, or prevents multiple myeloma (iStopMM) study Meeting Abstract


Authors: Kristinsson, S. Y.; Rögnvaldsson, S.; Thorsteinsdottir, S.; Reed, E. R.; Oskarsson, J. T. T.; Petursdottir, I.; Sigurdardottir, G. A.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; Sigurdardottir, M.; Thorsteinsdottir, I.; Sveinsdottir, S. V.; Palmason, R.; Olafsson, I.; Sigurdsson, F.; Thordardottir, A. R.; Eythorsson, E.; Jonsson, A.; Palsson, R.; Indridason, O. S.; Gislason, G. K.; Olafsson, A.; Sigurdsson, J. K.; Sverrisdottir, I. S.; Juliusdottir, M. S.; Hakonardottir, G. K.; Steingrimsdottir, H.; Danielsen, R.; Kampanis, P.; Hultcrantz, M.; Durie, B. G. M.; Harding, S.; Landgren, O.; Love, T. J.
Abstract Title: Screening for monoclonal gammopathy of undetermined significance: A population-based randomized clinical trial. First results from the Iceland screens, treats, or prevents multiple myeloma (iStopMM) study
Meeting Title: 63rd Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 138
Issue: Suppl. 1
Meeting Dates: 2021 Dec 11-14
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2021-11-23
Language: English
ACCESSION: WOS:000736398800154
DOI: 10.1182/blood-2021-152333
PROVIDER: wos
Notes: Meeting Abstract: 156 -- Hybrid meeting, also took place online -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work